NEW YORK--(BUSINESS WIRE)--BTIG announced today that the “BTIG Targeted Therapeutics Conference” will take place on Monday, February 24, 2020 in New York. The conference will be hosted by BTIG Biotechnology Analysts Tim Chiang, Robert “Bert” Hazlett, Amanda Murphy, CFA, and Thomas Shrader, PhD, CFA, and BTIG Healthcare Strategy and Franchise Sales Specialists Mikhail Keyserman, CMT, CFTe, and Michael Karmiol. The firm’s private event will include one-on-one meetings and thematic panels featuring key opinion leaders and leadership team members from several embryonic and mature therapeutic companies in the space.
Some of the topics for discussion include:
- Breast Cancer – The Moving Landscape
- Allogeneic/Off-the-Shelf – Where do we Stand with Progress/Challenges Using Novel Immune Effector Cells?
- Gene Therapy for Rare Diseases – How Do You Build More Than a One-Stop-Shop to Derive Value?
- Modulating Gene Expression with Small Genetic Elements
- DMD Treatments – Going from the Clinic to Commercial Scale
- Novel Targeted Small Molecule Oncologics – The Lifeblood of Biotech
- Neurodegeneration – Did the Recent P2 Data Support the New Model?
“Our moderators and panelists are each paving a unique path within the industry. Whether developing innovative therapeutic solutions, caring for patients or being a recognized thought leader, they are tasked with helping others better understand trends, products and what’s next within biotechnology,” commented David Lenchus, Director of Research at BTIG. “We are excited about the lineup of speakers we’ve attracted for our 2020 event and look forward to helping our clients and partners make more informed trading and investment decisions.”
BTIG’s Corporate Access program hosts client events across the consumer, energy, financials, healthcare, real estate, shipping and technology, media and telecommunications sectors.
For more information about the conference, email email@example.com. Please note that participants must be pre-registered to attend.
To access BTIG insights, contact a BTIG representative or visit www.btigresearch.com.
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 600 employees, BTIG, LLC and its affiliates operate out of 18 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. Disclaimer: https://www.btig.com/disclaimer.
To learn more about BTIG, visit www.btig.com.